16a-Hydroxy-17ß-estradiol-2,4 D2
| Product Name | 16a-Hydroxy-17ß-estradiol-2,4 D2 |
|---|---|
| Alternate Names | Estradiol Stable Isotopes, Stable Isotopes of Estradiol |
| CAT No. | CS-C-01035 |
| CAS No. | 53866-32-3 |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | 290.4 g/mol |
| Mol. For. | - |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Estradiol |
| Smileys | O[C@H]1[C@H](O)C[C@@]2([H])[C@]3([H])CCC4=C([2H])C(O)=C([2H])C=C4[C@@]3([H])CC[C@@]21C |
| Canonical Smiles | CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O |
| InchIKey | PROQIPRRNZUXQM-JOFMCETISA-N |
| Inchl | InChI=1S/C18H24O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-17,19-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1/i3D,8D |
| IUPAC | (8R,9S,13S,14S,16R,17R)-2,4-dideuterio-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
16a-Hydroxy-17ß-estradiol-2,4 D2 is a synthetic derivative of the hormone estradiol. It has been studied for its potential use as an estrogen replacement therapy for menopausal women. This compound has also been investigated for its potential as a treatment for breast cancer and osteoporosis.
Chemically, 16a-Hydroxy-17ß-estradiol-2,4 D2 is a modified form of estradiol that has an additional hydroxyl group at the 16a position. This modification increases the compound's affinity for the estrogen receptor and enhances its biological activity.
In terms of usage, 16a-Hydroxy-17ß-estradiol-2,4 D2 has been shown to be effective in reducing the frequency and severity of hot flashes, a common symptom experienced by menopausal women. It has also been shown to have positive effects on bone density and may be useful in preventing osteoporosis.
Despite its potential benefits, 16a-Hydroxy-17ß-estradiol-2,4 D2 may have side effects and risks associated with its use. Like other estrogen replacement therapies, it may increase the risk of blood clots, stroke, and breast cancer. It is important for individuals considering the use of this compound to discuss the potential risks and benefits with a healthcare provider.
Get an Instant Quote
Related Compounds
Estradiol-13C6 | Ethynyl Estradiol-13C2 | Ethinylestradiol sulfate-D4 | Estradiol 17-Palmitate-d31 | Estradiol Sulphate D4 sodium | Estradiol 17-Valerate-d9 | Sodium 17 β-Estradiol 3-Sulfate D4 | Ethynyl Estradiol-2,4,9,6,6,16,16- D7 | Estradiol D4 | Ethinylestradiol -D4 |